搜索筛选:
搜索耗时0.0941秒,为你在为你在102,285,761篇论文里面共找到 10 篇相符的论文内容
发布年度:
Hypofractionated Radiotherapy in Glioblastoma: Strategy for Poorrisk Patients or Hope for the Future
[会议论文] 作者：Mohan Hingorani,
来源：2013第六届世界癌症大会 年份：2013
The prognosis of patients with glioblastoma (GBM) remains poor, and the use of hyperfractionation or dose escalation beyond 60 Gy has not conferred any survival benefit.More recently, hypofracfionated...
Neoadjuvant Chemoradiotherapy for Resectable Oesophageal and Gastrooesophageal Junction Cancer-stand
[会议论文] 作者：Mohan Hingorani,
来源：BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会) 年份：2012
The management of localised oesophageal and gastro-oesophageal (GO J) cancer has significantly evolved over last few years.Neo-adjuvant therapy is commonly employed to downstage the primary tumour and...
Sequential maximum androgen blockade （MAB） in minimally symptomatic prostate cancer progressing afte
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,F,
来源：癌症生物学与医学：英文版 年份：2014
The management of castrate-resistant prostate cancer progressing after maximum androgen blockade(MAB) has evolved in the last decade with the development of sev...
Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-r
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,P,
来源：癌症生物学与医学：英文版 年份：2015
Palliative radiotherapy(pRT) is primarily employed for palliation of bone pain in patients with castrate-resistant prostate cancer(CRPC). However, evidence that...
Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing afte
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,F,
来源：癌症生物学与医学（英文版） 年份：2004
Te management of castrate-resistant prostate cancer progressing atfer maximum androgen blockade (MAB) has evolved in the last decade with the development of sev...
Can palliative radiotherapy inlfuence prostate-speciifc antigen response in patients with castrate-r
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,P,
来源：癌症生物学与医学（英文版） 年份：2015
Palliative radiotherapy (pRT) is primarily employed for palliation of bone pain in patients with castrate-resistant prostate cancer (CRPC). However, evidence th...
Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing afte
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,F,
来源：癌症生物学与医学（英文版） 年份：2014
Te management of castrate-resistant prostate cancer progressing atfer maximum androgen blockade (MAB) has evolved in the last decade with the development of sev...
Can palliative radiotherapy influence prostate-specific antigen response in patients with castrate-r
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,Pattu Pugazhenthi,Simon Hawkyard,Andrew Robertson,Richard Khafagy,,
来源：Cancer Biology & Medicine 年份：2015
Palliative radiotherapy(pRT) is primarily employed for palliation of bone pain in patients with castrate-resistant prostate cancer(CRPC). However, evidence that...
Can palliative radiotherapy inlfuence prostate-speciifc antigen response in patients with castrate-r
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,Pattu Pugazhenthi,Simon Hawkyard,Andrew Robertson,Richard Khafagy,
来源：癌症生物学与医学（英文版） 年份：2004
Palliative radiotherapy (pRT) is primarily employed for palliation of bone pain in patients with castrate-resistant prostate cancer (CRPC). However, evidence th...
Sequential maximum androgen blockade(MAB) in minimally symptomatic prostate cancer progressing after
[期刊论文] 作者：Mohan Hingorani,Sanjay Dixit,Fahim Bashir,Mohammad Butt,Simon Hawkyard,Richard Khafagy,Andrew Robertson,
来源：Cancer Biology & Medicine 年份：2014
The management of castrate-resistant prostate cancer progressing after maximum androgen blockade(MAB) has evolved in the last decade with the development of sev...
相关搜索：
